Physician profile
Pamela E Nickson
NPI 1629033048
$1,820.45
in general payments reported to CMS, 2019-2025
20 companies · $248 in 2025
The $248 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $14.42 · 2021: $512 · 2022: $111 · 2023: $396 · 2024: $402 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $326.59 | 2019-2025 | Vaxneuvance, Vaxelis, M-M-R II |
| Preventric Diagnostics, INC. | $320.95 | 2021 | |
| Sanofi Pasteur INC. | $265.86 | 2019-2025 | |
| Glaxosmithkline, LLC. | $227.64 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Sobi, INC | $176.79 | 2019-2023 | |
| Novo Nordisk INC | $68.42 | 2021 | |
| Pfizer INC. | $59.56 | 2023-2024 | |
| Exact Sciences Corporation | $49.83 | 2024 | Cologuard Collection Kit |
| Viiv Healthcare Company | $45.94 | 2025 | Apretude |
| Alk-Abello, INC | $45.41 | 2024 | Grastek, Ragwitek, Odactra |
| Cranial Technologies, INC | $42.66 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $23.95 | 2025 | |
| Xeris Pharmaceuticals, INC. | $23.58 | 2024 | Gvoke Hypopen |
| Abbvie INC. | $23.43 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.23 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $20.99 | 2024 | Immunocap |
| Biogen, INC. | $19.65 | 2025 | Zurzuvae |
| Amgen INC. | $19.03 | 2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $18.98 | 2025 | |
| Seqirus USA INC | $17.96 | 2025 | Fluad, Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Nickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.